Candesartan Cilexetil

Producers shown on SFDA

(Record date:01/09/2021）

Producers shown on EP

(Quoted from EP website；record date:01/09/2021）

Producer:Zhejiang Tianyu Pharmaceutical Co., Ltd., founded in 2003, is headquartered in Taizhou, Zhejiang, with a registered capital of more than 180 million yuan. It has six wholly-owned subsidiaries and more than 3800 employees. Tianyu Co., Ltd. is a joint-stock pharmaceutical enterprise specializing in R & D, manufacturing and sales of APIs and advanced pharmaceutical intermediates. It was successfully listed on Shenzhen Stock Exchange on September 19, 2017.

The company's main products include antihypertensive, hypoglycemic, antithrombotic and antiasthmatic drug raw materials and intermediates. It is one of the world's major manufacturers of cardiovascular raw materials, and its products sell well in markets at home and abroad.

Registered capital:RMB 348 million

Producer:Zhejiang Kinglyuan Pharmaceutical Co., Ltd.is located on the Bank of Hangzhou Bay, Zhejiang Province, with beautiful scenery, pleasant climate and superior geographical location. The company covers an area of 180000 square meters, has assets of 680 million yuan, and has 560 employees, including 32 with senior professional titles, and intermediate and other relevant technicians account for 42% of the total number of employees. After more than ten years of development, the company has become a comprehensive pharmaceutical enterprise integrating R & D, production and service.

Staff size:About 560 persons

Registered capital:RMB 68.2 million

Producer:Tiandi Hinye Pharmaceutical Co., Ltd. was established in 2006. The company covers an area of 60 mu. The first phase of the project has built a 4000 square meter frame structure plant and supporting facilities including four solid preparation production lines.

The company's products include Chinese patent medicine, chemical medicine and API. There are more than 100 drug R & D projects under research and declared to the State Drug Administration, including generic and innovative drugs of Chinese patent medicine and chemical medicine.

Registered capital:RMB 112 million

Producer:Fuzhou Jinshan Biological Pharmaceutical Co., Ltd., covering a total area of about 40000 square meters, was built in 1999. It is a leading enterprise under Fujian Jinshan Pharmaceutical Industry Group Co., Ltd.

At present, it has a small volume injection workshop, external ointment workshop and chemical API workshop, all of which have passed the national GMP certification. The company has advanced technical equipment, perfect detection system, unique process technology and scientific management system. It is engaged in the production of more than ten kinds of high-tech products in three dosage forms: injection, software paste and patch of biochemical immune function drugs, antifungal drugs, analgesics, antitumor drugs and antibiotics.

Registered capital:RMB 45.29 million

Producer:The company is now deregistered

Weihai Disu Pharmaceutical Co., Ltd., established in May 2005, is a subsidiary of Disha Pharmaceutical Group. It is a national high-tech enterprise integrating R & D, production and sales of chemical APIs, veterinary drugs, marine biological new materials and their intermediates.

Registered capital:January 2022

Producer:Shanxi Huangcheng Xiangfu Pharmaceutical Co., Ltd., a subsidiary of Huangcheng Xiangfu group, is a modern pharmaceutical enterprise integrating scientific research, development and production. Founded in 2001, the company is located in Jincheng Economic and Technological Development Zone.

The business scope of Shanxi Huangcheng Xiangfu Pharmaceutical Co., Ltd. includes the production of API, tablet, hard capsule, granule, powder, dry suspension, membrane and health food; Traditional Chinese medicine extraction.

Registered capital:RMB 84 million 300 thousand

Producer:Zhejiang Yongning Pharmaceutical Co., Ltd., located in Taizhou, Zhejiang Province, has more than 100 product varieties in five categories, including chemical agents, chemical pharmaceutical intermediates, APIs, Chinese patent medicines and health products.   The company has fully passed the new national GMP certification, and some products have passed the certification of FDA, PMDA of Japan and KFDA of Korea, among which cefotiam hydrochloride is the standard of USP.
Staff size:900-999 persons

Registered capital:RMB 153.125 million

Producer:Chongqing Shenghuaxi Pharmaceutical Co., Ltd. was established in 1998 and officially restructured into a joint stock limited company in 2010; At present, the company has more than 900 employees. After more than ten years of development, it has been established   Jingjing is a high-tech API and pharmaceutical preparation enterprise integrating R & D, production and sales.

Taking new drug R & D as the core competitiveness of the enterprise, the company has built a large-scale scientific research system, with more than 200 full-time scientific and technological developers; The company invests more than 12% of its sales revenue into new drug research and development every year. The company has three production bases, with more than ten fully sterile API and non sterile API production workshops, fine, drying and charter workshops, as well as a number of pharmaceutical preparation workshops; It has an annual production capacity of more than one billion yuan for APIs and pharmaceutical preparations.

Staff size:About 800 persons

Registered capital:RMB 66 million

Producer:Zhejiang Huahai Pharmaceutical Co., Ltd.was founded in 1989 and headquartered in Zhejiang, China. The company has nearly 7000 employees and more than 40 subsidiaries around the world (including China, the United States, Japan, Germany, etc.As a leading enterprise in the internationalization of Chinese medicine, Huahai pharmaceutical is the first pharmaceutical company in China to pass the FDA preparation quality certification and independently own the Anda document number. It is also the first Chinese pharmaceutical company to realize large-scale preparation sales in the United States. It has established China's pharmaceutical quality image in the world's high-end pharmaceutical market.

Staff size:About 7000 persons

Registered capital:RMB 1 billion 492 million

Producer:Tipr Pharmaceutical Co., Ltd.Research Institute was formerly directly under the State Food and drug administration. The pharmaceutical products produced by the company mainly involve antipsychotics, non steroidal anti-inflammatory, analgesia and detoxification, hypoglycemic, antiviral, cardio cerebrovascular and other fields. The dosage forms include small volume injection, tablet, granule, hard capsule, oral liquid and API. All dosage forms have passed GMP certification. It is a designated production unit of national psychotropic drugs and a comprehensive high-tech enterprise.
Staff size:300-399 persons

Registered capital:RMB 50 million